Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit… Read More
Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies Seattle biotech startup Bonum Therapeutics raised $93 million less than two months after its parent company Good Therapeutics was bought… Read More
Roche to acquire Good Therapeutics’ lead drug program for $250M, plus milestone payments Pharmaceutical giant Roche will acquire Good Therapeutics, reeling in its lead program six years after the Seattle startup was founded… Read More
Good Therapeutics lands $8M to develop protein drugs that work only where needed in the body The news: Seattle startup Good Therapeutics has raised $8 million to advance its therapeutic proteins designed to operate only where… Read More
Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed.… Read More
Seattle biotech startup Good Therapeutics raises $11M to make smart cancer therapies Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11… Read More
